iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study
- PMID: 36112961
- DOI: 10.1182/blood.2022017296
iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study
Comment in
-
Engineered platelets for clinical application: a step closer.Blood. 2022 Dec 1;140(22):2314-2315. doi: 10.1182/blood.2022018291. Blood. 2022. PMID: 36454596 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources

